Keywords
Diagnosis
Treatment
Submitted : 2024-05-28
Accepted : 2024-06-12
Published : 2024-06-27
Abstract
The study focused on elaborating the role of GINS1 expression and its regulatory mechanisms in colon adenocarcinoma (COAD). Using the UALCAN informational index, GINS1 expression assessment unveiled a critical up-regulation in malignant cells that stood out from normal controls, suggesting its contribution to COAD expansion. Further dismantling GINS1 expression across various boundaries revealed unsurprising up-regulation in different malignant development stages, racial groups, genders, and age classes in COAD patients, characteristics for its imperative role in cancer progression. Moreover, this study investigated the promoter methylation status of GINS1, uncovering a critical uniqueness between COAD samples and normal controls. Analyzing promoter methylation across various clinical boundaries uncovered powerful variations, with particular methylation patterns seen across cancer stages, race groups, genders, and age groups. Survival analysis using the Kaplan-Meier (KM) plotter tool showed a colossal connection between GINS1 expression levels and overall survival (OS) in COAD patients, with low GINS1 expression interfacing with higher OS. Additionally, mutational examination using the cBioPortal stage revealed that no critical change was found in COAD. Overall, these findings revealed the complex contribution of GINS1 in COAD pathogenesis, underlining its actual limit as a prognostic biomarker and supportive therapeutic agent in COAD management.
References
Ahmad M, Hameed Y, Khan M, et al., 2021, Up-Regulation of GINS1 Highlighted a Good Diagnostic and Prognostic Potential of Survival in Three Different Subtypes of Human Cancer. Braz J Biol, (84): e250575.
Bu F, Zhu X, Zhu J, et al., 2020, Bioinformatics Analysis Identifies a Novel Role of GINS1 Gene in Colorectal Cancer. Cancer Manag Res, (12): 11677–11687.
Zhang W, Hu Y, Yi K, et al., 2022, The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4. J Immunol Res, (2022): 9385820.
Bray F, Ferlay J, Soerjomataram I, et al., 2018, Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 68(6): 394–424.
Yang H, Li Q, Wu Y, et al., 2020, Long Non?Coding RNA RP11?400N13.3 Promotes the Progression of Colorectal Cancer by Regulating the miR?4722?3p/P2RY8 Axis. Oncol Rep, 44(5): 2045–2055.
Xu L, Li X, Cai M, et al., 2016, Increased Expression of Solute Carrier Family 12 Member 5 Via Gene Amplification Contributes to Tumour Progression and Metastasis and Associates with Poor Survival in Colorectal Cancer. Gut, 65(4): 635–646.
Chen W, An P, Quan XJ, et al., 2017, Ca2+/Calmodulin-Dependent Protein Kinase II Regulates Colon Cancer Proliferation and Migration Via ERK1/2 and p38 Pathways. World J Gastroenterol, 23(33): 6111–6118.
Chen J, Wang Z, Shen X, et al., 2019, Identification of Novel Biomarkers and Small Molecule Drugs in Human Colorectal Cancer by Microarray and Bioinformatics Analysis. Mol Genet Genomic Med, 7(7): e00713.
Li T, Fu J, Zeng Z, et al., 2020, TIMER2.0 for Analysis of Tumor-Infiltrating Immune Cells. Nucleic Acids Res, 48(W1): W509–W14.
Chandrashekar DS, Bashel B, Balasubramanya SAH, et al., 2017, UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia, 19(8): 649–658.
Cerami E, Gao J, Dogrusoz U, et al., 2012, The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov, 2(5): 401–404.
Toda H, Seki N, Kurozumi S, et al., 2020, RNA-Sequence-Based MicroRNA Expression Signature in Breast Cancer: Tumor-Suppressive miR-101-5p Regulates Molecular Pathogenesis. Mol Oncol, 14(2): 426–446.
Yamane K, Naito H, Wakabayashi T, et al., 2016, Regulation of SLD5 Gene Expression by miR-370 During Acute Growth of Cancer Cells. Sci Rep, (6): 30941.
Chang YP, Wang G, Bermudez V, et al., 2007, Crystal Structure of the GINS Complex and Functional Insights into Its Role in DNA Replication. Proc Natl Acad Sci USA, 104(31): 12685–12690.
Nakahara I, Miyamoto M, Shibata T, et al., 2010, Up-Regulation of PSF1 Promotes the Growth of Breast Cancer Cells. Genes Cells, 15(10): 1015–1024.
Xing Z, Luo Z, Yang H, et al., 2019, Screening and Identification of Key Biomarkers in Adrenocortical Carcinoma Based on Bioinformatics Analysis. Oncol Lett, 18(5): 4667–4676.
Zhou L, Sun XJ, Liu C, et al., 2015, Overexpression of PSF1 is Correlated with Poor Prognosis in Hepatocellular Carcinoma Patients. Int J Biol Markers, 30(1): e56–64.
Baade PD, Youlden DR, Cramb SM, et al., 2013, Epidemiology of Prostate Cancer in the Asia-Pacific Region. Prostate Int, 1(2): 47–58.